 |
- goat polyclonal IgG, 200 µg/ml
- epitope mapping within an internal region of FHL-2 of human origin
- recommended for detection of FHL-2 of mouse, rat and human origin by WB, IP, IF and ELISA; also reactive with additional species, including equine, canine, bovine, porcine and avian
- blocking peptide, sc-26316 P
|
|
| |
Ordering Information
Recommended Support Products:
(click button of application of choice)
FHL-2 Background Information The four-and-a-half-LIM domain (FHL) proteins include FHL-1 (SLIM1), FHL-2 (SLIM3), FHL-3 (SLIM2) and FHL-4. The signature “half-domain”, a single zinc finger domain located in the N-terminal region, differentiates FHLs from other LIM-only proteins, which have numbers of zinc fingers. Specific combinations of FHL proteins elicit selective activation of both CREB and CREM. Skeletal and cardiac muscle express FHL-1 in high levels as compared to the low level of expression in smooth muscle of the colon, small intestine and prostate. FHL-1 localizes to the cytosol of myoblasts, myotubes, and differentiated myocytes. FHL-2 is also located in cardiac and skeletal muscle, as well as in placenta and ovary tissues. FHL-3 is found in skeletal muscle, but absent in cardiac muscle. FHL-4 is expressed exclusively by the seminiferous epithelium of the testis, which suggests that FHL-4 is involved in spermatogenesis. The genetic loci for FHLs vary considerably despite similiar amino acid sequences among the FHL group. |
 |
|
FHL-2 (T-14)
Click on image to enlarge
|
FHL-2 (T-14): sc-26316. Western blot analysis of FHL-2 expression in non-transfected: sc-117752 (A) and mouse FHL-2 transfected: sc-120254 (B) 293T whole cell lysates.
|
|
Download
|
|